Today: 9 April 2026
Rocket Lab stock price today: RKLB slips after hours as Neutron tank test rupture keeps timeline in focus
24 January 2026
2 mins read

Rocket Lab stock price today: RKLB slips after hours as Neutron tank test rupture keeps timeline in focus

New York, January 23, 2026, 18:37 EST — After-hours trading

  • Shares of Rocket Lab climbed 1.1% during the regular session before slipping in after-hours trading
  • During Neutron qualification testing, the company reported a Stage 1 tank rupture; the impact on the schedule is still being assessed
  • Rocket Lab completed its first Electron launch of 2026 and has another mission scheduled for next week

Rocket Lab Corporation’s shares ended Friday up 1.1% at $88.90, only to dip 0.4% to $88.53 after hours. During the day, the stock swung between $86.12 and $94.45, with about 24 million shares changing hands. StockAnalysis

The late drop follows news of a hiccup with Neutron, Rocket Lab’s next-gen rocket. During an overnight qualification test, the Stage 1 tank ruptured under hydrostatic pressure—a water pressure test designed to push the tank to its breaking point. “Testing failures are not uncommon during qualification testing,” Rocket Lab said, noting it will analyze the data to determine any effects on the launch timeline. SEC

Why it matters now: Neutron is the key to Rocket Lab’s shift from its smaller Electron rocket toward high-volume tasks like constellation launches and national-security contracts. That market is packed and fast-moving, so any hold-ups quickly undermine trust.

TD Cowen analyst Gautam Khanna raised concerns about potential fallout from a slip. He noted, “If a launch delay results from the tank rupture, a second Neutron launch in 2026 would be unlikely,” citing Aviation Week’s report that the initial flight was slated for the second quarter. Aviation Week

Rocket Lab pushed forward with Electron as it develops Neutron. On Thursday, it launched two Open Cosmos satellites from Mahia, New Zealand—marking its first mission of 2026. Founder and CEO Sir Peter Beck described the flight as “a great showcase of the benefits of flying dedicated on Electron.” GlobeNewswire

The company announced that the mission, “The Cosmos Will See You Now,” placed the pair into a circular low-Earth orbit roughly 1,050 km up. Rocket Lab noted this flight profile showcased Electron’s capability to reach a broader range of orbits, appealing to customers keen to skip ride-share timetables. Rocket Lab

A separate regulatory filing added another data point as the stock fluctuated. Director Jon A. Olson offloaded 15,205 shares on Jan. 20, according to a Form 4 filing, doing so under a Rule 10b5-1 plan — an insider trading arrangement established in advance. After the sale, Olson reported holding 345,630 shares. SEC

Neutron aims to carry significantly heavier loads than Electron, targeting missions where SpaceX’s Falcon 9 dominates on cost and launch frequency. According to The Register, Neutron is built to deliver roughly 13,000 kg to low-Earth orbit and then return for reuse. The tank test was conducted at Rocket Lab’s Space Structures Complex in Middle River, Maryland. The Register

The immediate risk is clear: if qualification testing reveals more structural problems, addressing them could push timelines and raise costs. Rocket Lab hasn’t shared much about how much cushion exists in its Neutron schedule. Another setback would probably shift investor attention back to cash burn, upcoming milestones, and the true meaning behind the “February update.”

Up next, Rocket Lab has issued a launch safety notice for an Electron mission dubbed “Bridging the Swarm.” The liftoff is set for no earlier than Jan. 28 from Launch Complex 1 in New Zealand, with backup dates stretching through Feb. 9. Investors will also be keenly awaiting the company’s Neutron schedule update during its February earnings call. Rocket Lab

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Mastercard stock slips as JPMorgan flags “slight” spending slowdown ahead of earnings
Previous Story

Mastercard stock slips as JPMorgan flags “slight” spending slowdown ahead of earnings

Eli Lilly stock slips after hours as obesity-pill race stays in the spotlight
Next Story

Eli Lilly stock slips after hours as obesity-pill race stays in the spotlight

Go toTop